Tumor tissue expression of proteins AFP, TGFBR2, pSMAD2, E-cadherin, PIVKAII, cMET and Glypican-3 was analysed to determine relationship to clinical outcomes in Part A or Part B, separately or combined. This evidence concerns the gene MET and neoplasm.